2012
DOI: 10.4161/onci.20225
|View full text |Cite
|
Sign up to set email alerts
|

The protooncogene Vav1 regulates murine leukemia virus-induced T-cell leukemogenesis

Abstract: Vav1 is expressed exclusively in hematopoietic cells and is required for T cell development and activation. Vav1-deficient mice show thymic hypocellularity due to a partial block during thymocyte development at the DN3 stage and between the double positive (DP) and single positive (SP) transition. Vav1 has been shown to play a significant role in several non-hematopoietic tumors but its role in leukemogenesis is unknown. To address this question, we investigated the role of Vav1 in retrovirus-induced T cell le… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2014
2014
2015
2015

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 36 publications
0
1
0
Order By: Relevance
“…Target cell availability is probably maximal for NK cells in blood borne cancers, hence, we believe that these diseases will show the highest CD45RARO NK cell numbers; although these cells are unable to control the disease. Leukemogenesis in mouse is enhanced when the host immune system is impaired ( Garaude et al, 2008 , Kaminski et al, 2012 ) and more hematological cancer patients present severe NK cell dysfunctions ( Baier et al, 2013 ). Others and we have shown the requirement of fully functional NK cells to eradicate blood-borne tumors in several mouse models ( Karre et al, 1986 , Van Den Broek et al, 1995 , Pardo et al, 2002 , Aguilo et al, 2009 , Charni et al, 2009 , Charni et al, 2010 , Ramírez-Comet et al, 2014 ).…”
Section: Discussionmentioning
confidence: 99%
“…Target cell availability is probably maximal for NK cells in blood borne cancers, hence, we believe that these diseases will show the highest CD45RARO NK cell numbers; although these cells are unable to control the disease. Leukemogenesis in mouse is enhanced when the host immune system is impaired ( Garaude et al, 2008 , Kaminski et al, 2012 ) and more hematological cancer patients present severe NK cell dysfunctions ( Baier et al, 2013 ). Others and we have shown the requirement of fully functional NK cells to eradicate blood-borne tumors in several mouse models ( Karre et al, 1986 , Van Den Broek et al, 1995 , Pardo et al, 2002 , Aguilo et al, 2009 , Charni et al, 2009 , Charni et al, 2010 , Ramírez-Comet et al, 2014 ).…”
Section: Discussionmentioning
confidence: 99%